FDA Clearance Tracker · P060002-S034
FLAIR ENDOVASCULAR STENT GRAFT
Last checked: Nov 20, 2026Latest source record: Aug 13, 2014 (this decision)Source: openFDAMethods & limitations
Decided
Aug 13, 2014
Approved
Time to decision
180 days
Received Feb 14, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P060002-S034
- Device name
- FLAIR ENDOVASCULAR STENT GRAFT
- Applicant
- Bard Peripheral Vascular
- Applicant location
- Tempe, AZ
- Received
- Feb 14, 2014
- Decided
- Aug 13, 2014
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P060002
Device type
- Device type
- System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment (PFV)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR UPDATED INSTRUCTIONS FOR USE (IFU) TO INCLUDE DATA FROM THE POSTAPPROVAL STUDY (RENOVA).
Source documents
Other decisions for Bard Peripheral Vascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250050 · Decided Sep 25, 2026 · 303 days after receipt
Device type: SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS (MIR) · Cardiology
K262571 · Decided Aug 14, 2026 · 21 days after receipt
Device type: Instrument, Biopsy (KNW) · GI, Urology & Nephrology
K260012 · Decided Feb 4, 2026 · 30 days after receipt
Device type: Catheter, Percutaneous, Cutting/Scoring (PNO) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.